Item 7.01 Regulation FD Disclosure.

On October 14, 2020, Nurix Therapeutics, Inc. (the "Company") presented at the 3rd Targeted Protein Degradation Summit (the "Presentation"). A copy of the Presentation, which will be available on the Company's website at www.nurixtx.com under the tab "Investor," is attached hereto as Exhibit 99.1, and is incorporated herein by reference.

The information furnished with this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.






(d) Exhibits




                Exhibit
                  No.     Exhibit Title or Description

                99.1        Presentation dated October 14, 2020

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses